This article was reviewed by Daniel Z. Lieberman, MD. If you’re struggling with depression, anxiety, insomnia or another issue affecting your mental health, you may have heard of the tricyclic ...
SAN DIEGO, Mar 18, 2010 (BUSINESS WIRE) -- --Conference call scheduled today at 9:00 a.m. PT (12:00 p.m. ET); Simultaneous webcast at http://investors.somaxon.com ...
Somaxon Pharmaceuticals, Inc. Provides Update on New Drug Application for Silenor (doxepin) for the Treatment of Insomnia; Plans Additional Analyses of Clinical Data SAN DIEGO -- Somaxon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results